Drug Management in Heart Failure

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele Roma

About this trial

Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality

Eligibility criteria

Qualifiers

Both gender

Age >18 years

Signed informed consent for the study

Known diagnosis of heart failure > 6 months

Disqualifiers

Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons

Concurrent diagnosis of neoplasia

Advanced COPD (FEV1 <50%)

Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

IRCCS San Raffaele Roma

Lead sponsor

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Collaborator

Azienda Ospedaliera Universitaria Mater Domini, Catanzaro

Collaborator